First reported by thehindubusinessline.com
Novo Nordisk India rolls-out a once-weekly basal insulin Awiqli
Novo Nordisk launches world's first once-weekly basal insulin in India
4h agoen
From the article
New Delhi [India], July 9 (ANI): Novo Nordisk India on Thursday announced the launch in India of Awiqli (insulin icodec), the world's first weekly once-basal insulin for adults with Type 1 or Type 2 diabetes mellitus. The product reduces the insulin regimen from once-daily to once-weekly - or 365 shots to 52. The company describes this as a fundamental reimagining of how insulin fits into people's lives rather th
Continue reading on bignewsnetwork.comYou might also wanna read
Novo Nordisk India rolls-out a once-weekly basal insulin Awiqli
thehindubusinessline.com·10h ago
Novo Nordisk: Schritt für Schritt
aktiencheck.de
Novo Nordisk launches first GLP-1 weight loss pill Wegovy in US at lower price than injections
Novo Nordisk has launched the first pill version of its blockbuster GLP-1 weight loss drug Wegovy in the US at a significantly lower price t
theguardian.com·6mo agoNovo Nordisk: Wachstum im Diabetes- und Adipositasmarkt – Innovation, Kapazitäten und Pipeline-Fokus
IT BOLTWISE·1d ago
Wegovy weight-loss pill goes on sale on UK high street and online pharmacies
The Guardian·3d ago
Wegovy weight-loss pill goes on sale on UK high street and online pharmacies
The Guardian·3d ago
Novo Nordisk-Aktie: Singapur-News? First-Mover-Vorteil bleibt wichtiger!
aktiencheck.de
Comments
Sign in to join the conversation.
No comments yet. Be the first.